Scarica l'app Stockscreener
7.505
1.66%
-0.115
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.62
Aprire:
$7.65
Volume 24 ore:
1.50M
Relative Volume:
0.16
Capitalizzazione di mercato:
$873.80M
Reddito:
$829.22M
Utile/perdita netta:
$-248.96M
Rapporto P/E:
-25.02
EPS:
-0.3
Flusso di cassa netto:
$-92.10M
1 W Prestazione:
+6.29%
1M Prestazione:
-19.42%
6M Prestazione:
-21.16%
1 anno Prestazione:
-21.06%
Intervallo 1D:
$7.41
$7.835
Intervallo di 1 settimana:
$7.16
$8.305
Portata 52W:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
7.50 | 887.78M | 829.22M | -248.96M | -92.10M | -0.30 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.36 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.16 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.19 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.97 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
478.24 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Hold |
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray Brands, Inc. - Baystreet.ca
Tilray (TLRY) Pharma Expands UK Reach Through Strategic Agreemen - GuruFocus
Tilray Brief: Expanding UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals - marketscreener.com
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals - GlobeNewswire
Tilray Brands (NASDAQ:TLRY) Shares Down 2.7%Should You Sell? - MarketBeat
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Is Tilray stock going to $0? - MSN
Tilray Brands (NASDAQ:TLRY) Trading Up 1.7%Here's Why - MarketBeat
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
Is Tilray Stock Going to $0? - Nasdaq
Tilray Brands (NASDAQ:TLRY) Trading Up 1.6%What's Next? - MarketBeat
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Tilray Shares Blazing: What's Behind the 55% Rally This Month? - MSN
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Tilray Shares Surge on Sector Strength and Strategic Progress - AD HOC NEWS
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Tilray’s Beverage Division Gains Momentum Amid Cannabis Sector Volatility - AD HOC NEWS
Tilray Builds Medical Cannabis And Spirits Pillars As Share Performance Lags - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Price Up 7.5%Time to Buy? - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Tilray’s Mixed Quarter: Record Revenue Amid Segment Divergence - AD HOC NEWS
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Tilray Brands (NASDAQ:TLRY) Shares Down 7.2%Time to Sell? - MarketBeat
Best Cannabis Stocks To Keep An Eye OnFebruary 5th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Down 2.3%What's Next? - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistFebruary 4th - MarketBeat
Stocks in play: Tilray Brands, Inc. - The Globe and Mail
New distributor brings Breckenridge bourbon and rum to more Illinois shelves - stocktitan.net
CC Pharma Recognized as a TOP 100 Innovator in Germany by Tilray Brands, Inc. - Quiver Quantitative
Tilray’s CC Pharma serves 13,000 German pharmacies, wins TOP 100 award - Stock Titan
Tilray Leverages Craft Beer Portfolio for Major US Sports Weekend - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Stock Price Up 4.6%Should You Buy? - MarketBeat
Top Cannabis Stocks To ResearchFebruary 3rd - MarketBeat
Tilray Brands stock has crashed—but a bullish pattern is emerging - TradingView
Tilray Brands Ignites Championship Sunday: Nationwide Tap - GlobeNewswire
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Has Debt But No Earnings; Should You Worry? - 富途牛牛
Cannabis Stocks To Add to Your WatchlistFebruary 2nd - MarketBeat
(TLRY) Technical Patterns and Signals (TLRY:CA) - Stock Traders Daily
Best Cannabis Stocks To Follow TodayJanuary 31st - MarketBeat
Tilray Medical Italia Puts European Cannabis Growth Story To The Test - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.1%Here's Why - MarketBeat
Is Tilray Brands (TLRY) Offering Opportunity After Prolonged Share Price Declines - Yahoo Finance
A Look At Tilray Brands (TLRY) Valuation As Beverage Initiatives Draw Fresh Attention - Yahoo Finance
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now? - The Globe and Mail
Tilray Brands (NASDAQ:TLRY) Shares Down 2.9%Time to Sell? - MarketBeat
Tilray’s Q2 2026 Results: A Story of Diverging Segments - AD HOC NEWS
Top Cannabis Stocks To Watch TodayJanuary 29th - MarketBeat
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture - Finviz
Tilray (TLRY) Unveils Fresh Branding for Terrapin Beer - GuruFocus
Tilray Shares Navigate Choppy Waters Amid Conflicting Signals - AD HOC NEWS
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SIMON IRWIN D | President and CEO |
Jul 31 '25 |
Option Exercise |
0.58 |
706,216 |
409,605 |
5,200,788 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
0.56%
10.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):